Trial Outcomes & Findings for Telehealth Delivery (Tele-B6) (NCT NCT05829759)

NCT ID: NCT05829759

Last Updated: 2026-04-20

Results Overview

Post-session evaluation forms were administered after each intervention session and were evaluated collectively at the end of the study. This evaluation form included 7 statements (examples: "I felt comfortable in this virtual space", "I am confident I can apply the tools we learned today to my life") to be answered on a 5-point Likert scale (e.g., 5=strongly agree, 4=agree, 3=neutral, 2=disagree, 1=strongly disagree) as well as open ended questions (e.g., what did you like most?)

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

60 participants

Primary outcome timeframe

Study Exit (up to 6 months)

Results posted on

2026-04-20

Participant Flow

Summary results include only Phase 2, the randomized clinical trial, and participants who consented and participated in the online intervention. No consent or outcome data were collected in Phases 1 or 3, which were conducted solely to develop and adapt the program for online delivery and implementation. Participants were recruited from community and clinical partners in Atlanta. Enrollment began April 18, 2023; follow-up ended November 5, 2024.

Survey assessments for the Tele-B6 arm were conducted at enrollment (baseline), 2 months (post-intervention), 4 months (interim, post-intervention), and 6 months (endline). Wait-list control (delayed intervention) participants began the full intervention at month 2, after their matched Tele-B6 completed the program and one follow-up survey. The wait-list control arm completed surveys at baseline, 2 months (pre-intervention), 4 months (immediate post-intervention), and 6 months (endline).

Participant milestones

Participant milestones
Measure
Tele-B6
The tele-B6 intervention includes five group sessions delivered over the course of five weeks. Survey assessments for the intervention group will be conducted at enrollment (baseline), 2 months (immediate post-intervention survey), 4 months (interim-survey, post-intervention), and 6 months (endline). Tele-B6: Participants will be part of the Tele-B6 intervention that includes five group sessions delivered over the course of five weeks. Survey assessments for the intervention group (first phase) will be conducted at enrollment (baseline), 2 months (immediate post-intervention survey), 4 months (interim-survey, post-intervention), and 6 months (endline).
Wait-list Control -Delayed Intervention
A wait-list control design to safeguard ethical treatment of participants by ensuring that a potentially impactful intervention will be available to all after a brief waiting period. Delayed intervention (waitlist control): Wait-list control participants will be assigned to initiate the full intervention at month 2 after their enrollment (i.e., after they and their corresponding intervention group have completed their intervention and one follow-up survey). Wait-list control participants will complete surveys at enrollment (baseline), 2 months (pre-intervention), 4 months (immediate post-intervention), and 6 months (endline).
First Phase (Original Intervention Group
STARTED
30
30
First Phase (Original Intervention Group
COMPLETED
24
25
First Phase (Original Intervention Group
NOT COMPLETED
6
5
Second Phase
STARTED
24
25
Second Phase
COMPLETED
24
23
Second Phase
NOT COMPLETED
0
2

Reasons for withdrawal

Reasons for withdrawal
Measure
Tele-B6
The tele-B6 intervention includes five group sessions delivered over the course of five weeks. Survey assessments for the intervention group will be conducted at enrollment (baseline), 2 months (immediate post-intervention survey), 4 months (interim-survey, post-intervention), and 6 months (endline). Tele-B6: Participants will be part of the Tele-B6 intervention that includes five group sessions delivered over the course of five weeks. Survey assessments for the intervention group (first phase) will be conducted at enrollment (baseline), 2 months (immediate post-intervention survey), 4 months (interim-survey, post-intervention), and 6 months (endline).
Wait-list Control -Delayed Intervention
A wait-list control design to safeguard ethical treatment of participants by ensuring that a potentially impactful intervention will be available to all after a brief waiting period. Delayed intervention (waitlist control): Wait-list control participants will be assigned to initiate the full intervention at month 2 after their enrollment (i.e., after they and their corresponding intervention group have completed their intervention and one follow-up survey). Wait-list control participants will complete surveys at enrollment (baseline), 2 months (pre-intervention), 4 months (immediate post-intervention), and 6 months (endline).
First Phase (Original Intervention Group
Lost to Follow-up
6
4
First Phase (Original Intervention Group
Withdrawal by Subject
0
1
Second Phase
Lost to Follow-up
0
2

Baseline Characteristics

Telehealth Delivery (Tele-B6)

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Tele-B6
n=30 Participants
The tele-B6 intervention includes five group sessions delivered over the course of five weeks. Survey assessments for the intervention group will be conducted at enrollment (baseline), 2 months (immediate post-intervention survey), 4 months (interim-survey, post-intervention), and 6 months (endline). Tele-B6: Participants will be part of the Tele-B6 intervention that includes five group sessions delivered over the course of five weeks. Survey assessments for the intervention group (first phase) will be conducted at enrollment (baseline), 2 months (immediate post-intervention survey), 4 months (interim-survey, post-intervention), and 6 months (endline).
Wait-list Control -Delayed Intervention
n=30 Participants
A wait-list control design to safeguard ethical treatment of participants by ensuring that a potentially impactful intervention will be available to all after a brief waiting period. Delayed intervention (waitlist control): Wait-list control participants will be assigned to initiate the full intervention at month 2 after their enrollment (i.e., after they and their corresponding intervention group have completed their intervention and one follow-up survey). Wait-list control participants will complete surveys at enrollment (baseline), 2 months (pre-intervention), 4 months (immediate post-intervention), and 6 months (endline).
Total
n=60 Participants
Total of all reporting groups
Age, Continuous
25.0 years
STANDARD_DEVIATION 4.1 • n=129 Participants
25.9 years
STANDARD_DEVIATION 2.6 • n=22 Participants
25.4 years
STANDARD_DEVIATION 3.5 • n=151 Participants
Sex: Female, Male
Female
0 Participants
n=129 Participants
0 Participants
n=22 Participants
0 Participants
n=151 Participants
Sex: Female, Male
Male
30 Participants
n=129 Participants
30 Participants
n=22 Participants
60 Participants
n=151 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=129 Participants
0 Participants
n=22 Participants
0 Participants
n=151 Participants
Race (NIH/OMB)
Asian
0 Participants
n=129 Participants
0 Participants
n=22 Participants
0 Participants
n=151 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=129 Participants
0 Participants
n=22 Participants
0 Participants
n=151 Participants
Race (NIH/OMB)
Black or African American
30 Participants
n=129 Participants
30 Participants
n=22 Participants
60 Participants
n=151 Participants
Race (NIH/OMB)
White
0 Participants
n=129 Participants
0 Participants
n=22 Participants
0 Participants
n=151 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=129 Participants
0 Participants
n=22 Participants
0 Participants
n=151 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=129 Participants
0 Participants
n=22 Participants
0 Participants
n=151 Participants
Region of Enrollment
United States
30 participants
n=129 Participants
30 participants
n=22 Participants
60 participants
n=151 Participants

PRIMARY outcome

Timeframe: Study Exit (up to 6 months)

Post-session evaluation forms were administered after each intervention session and were evaluated collectively at the end of the study. This evaluation form included 7 statements (examples: "I felt comfortable in this virtual space", "I am confident I can apply the tools we learned today to my life") to be answered on a 5-point Likert scale (e.g., 5=strongly agree, 4=agree, 3=neutral, 2=disagree, 1=strongly disagree) as well as open ended questions (e.g., what did you like most?)

Outcome measures

Outcome measures
Measure
Wait-list Control -Delayed Intervention
n=88 Surveys
A wait-list control design to safeguard ethical treatment of participants by ensuring that a potentially impactful intervention will be available to all after a brief waiting period. Delayed intervention (waitlist control): Wait-list control participants will be assigned to initiate the full intervention at month 2 after their enrollment (i.e., beginning after they and their corresponding intervention group have completed their intervention and one follow-up survey). Wait-list control participants will complete surveys at enrollment (baseline), 2 months (pre-intervention), 4 months (immediate post-intervention), and 6 months (endline).
Tele-B6
n=112 Surveys
The tele-B6 intervention includes five group sessions delivered over the course of five weeks. Survey assessments for the intervention group will be conducted at enrollment (baseline), 2 months (immediate post-intervention survey), 4 months (interim-survey, post-intervention), and 6 months (endline). Tele-B6: Participants will be part of the Tele-B6 intervention that includes five group sessions delivered over the course of five weeks. Survey assessments for the intervention group (first phase) will be conducted at enrollment (baseline), 2 months (immediate post-intervention survey), 4 months (interim-survey, post-intervention), and 6 months (endline).
Acceptability Scale
I felt comfortable in this virtual space
4.68 score on a scale
Standard Deviation 0.72
4.63 score on a scale
Standard Deviation 0.63
Acceptability Scale
I feel confident I can apply the tools we learned today to my life
4.70 score on a scale
Standard Deviation 0.75
4.60 score on a scale
Standard Deviation 0.65
Acceptability Scale
Any questions I had were clearly answered
4.73 score on a scale
Standard Deviation 0.69
4.65 score on a scale
Standard Deviation 0.63
Acceptability Scale
I feel like I got a lot out of the activities we did today
4.78 score on a scale
Standard Deviation 0.42
4.55 score on a scale
Standard Deviation 0.71
Acceptability Scale
The group discussions helped me learn about other people in the group
4.69 score on a scale
Standard Deviation 0.65
4.55 score on a scale
Standard Deviation 0.75
Acceptability Scale
How satisfied were you with the performance of the facilitators?
4.93 score on a scale
Standard Deviation 0.25
4.83 score on a scale
Standard Deviation 0.38
Acceptability Scale
Overall, how satisfied are you with today's session?
4.89 score on a scale
Standard Deviation 0.32
4.81 score on a scale
Standard Deviation 0.39

PRIMARY outcome

Timeframe: During intervention sessions up to 5 weeks (5 weeks total)

Attendance was assessed using session logs recorded at each intervention visit, capturing the number of sessions attended during the five-week intervention period. For the immediate intervention arm (Tele-B6), attendance was recorded from baseline through completion of the five-week intervention (up to 2 months post-enrollment). For the delayed intervention (wait-list control) arm, attendance was recorded during the five-week intervention delivered between months 2 and 4 of study participation.

Outcome measures

Outcome measures
Measure
Wait-list Control -Delayed Intervention
n=30 Participants
A wait-list control design to safeguard ethical treatment of participants by ensuring that a potentially impactful intervention will be available to all after a brief waiting period. Delayed intervention (waitlist control): Wait-list control participants will be assigned to initiate the full intervention at month 2 after their enrollment (i.e., beginning after they and their corresponding intervention group have completed their intervention and one follow-up survey). Wait-list control participants will complete surveys at enrollment (baseline), 2 months (pre-intervention), 4 months (immediate post-intervention), and 6 months (endline).
Tele-B6
n=30 Participants
The tele-B6 intervention includes five group sessions delivered over the course of five weeks. Survey assessments for the intervention group will be conducted at enrollment (baseline), 2 months (immediate post-intervention survey), 4 months (interim-survey, post-intervention), and 6 months (endline). Tele-B6: Participants will be part of the Tele-B6 intervention that includes five group sessions delivered over the course of five weeks. Survey assessments for the intervention group (first phase) will be conducted at enrollment (baseline), 2 months (immediate post-intervention survey), 4 months (interim-survey, post-intervention), and 6 months (endline).
Number of Attended Sessions
3.0 Number of sessions attended
Standard Deviation 2.13
3.73 Number of sessions attended
Standard Deviation 1.55

PRIMARY outcome

Timeframe: During study participation up to 6 months

Review of Adverse Event Tracking Forms during study participation up to six months.

Outcome measures

Outcome measures
Measure
Wait-list Control -Delayed Intervention
n=30 Participants
A wait-list control design to safeguard ethical treatment of participants by ensuring that a potentially impactful intervention will be available to all after a brief waiting period. Delayed intervention (waitlist control): Wait-list control participants will be assigned to initiate the full intervention at month 2 after their enrollment (i.e., beginning after they and their corresponding intervention group have completed their intervention and one follow-up survey). Wait-list control participants will complete surveys at enrollment (baseline), 2 months (pre-intervention), 4 months (immediate post-intervention), and 6 months (endline).
Tele-B6
n=30 Participants
The tele-B6 intervention includes five group sessions delivered over the course of five weeks. Survey assessments for the intervention group will be conducted at enrollment (baseline), 2 months (immediate post-intervention survey), 4 months (interim-survey, post-intervention), and 6 months (endline). Tele-B6: Participants will be part of the Tele-B6 intervention that includes five group sessions delivered over the course of five weeks. Survey assessments for the intervention group (first phase) will be conducted at enrollment (baseline), 2 months (immediate post-intervention survey), 4 months (interim-survey, post-intervention), and 6 months (endline).
Number of Participants Reporting Adverse Events (Safety)
0 Participants
0 Participants

SECONDARY outcome

Timeframe: 0, 2, 4, 6 months

Population: Participants analyzed were those who completed the required surveys at the specified timepoints and had valid data available for analysis

Participants will complete the material resources survey to measure socioeconomic status. The material resources survey has 18 questions that ask how often the participants' family needs are adequately met. Items addressed resources such as having food for two meals a day, a house or apartment, money to pay monthly bills, time to get enough sleep/rest, and money to save. There are six options (never=0; rarely=1; less than half of the time=w, about half of the time=3; more than half of the time=4; and always=5). A sum score was computed with a potential range from 0 (never enough resources for all items) to 5 (always enough resources for all items), with a higher score indicative of more resources. The highest score means that needs are adequately met.

Outcome measures

Outcome measures
Measure
Wait-list Control -Delayed Intervention
n=30 Participants
A wait-list control design to safeguard ethical treatment of participants by ensuring that a potentially impactful intervention will be available to all after a brief waiting period. Delayed intervention (waitlist control): Wait-list control participants will be assigned to initiate the full intervention at month 2 after their enrollment (i.e., beginning after they and their corresponding intervention group have completed their intervention and one follow-up survey). Wait-list control participants will complete surveys at enrollment (baseline), 2 months (pre-intervention), 4 months (immediate post-intervention), and 6 months (endline).
Tele-B6
n=30 Participants
The tele-B6 intervention includes five group sessions delivered over the course of five weeks. Survey assessments for the intervention group will be conducted at enrollment (baseline), 2 months (immediate post-intervention survey), 4 months (interim-survey, post-intervention), and 6 months (endline). Tele-B6: Participants will be part of the Tele-B6 intervention that includes five group sessions delivered over the course of five weeks. Survey assessments for the intervention group (first phase) will be conducted at enrollment (baseline), 2 months (immediate post-intervention survey), 4 months (interim-survey, post-intervention), and 6 months (endline).
The Material Resources Survey
4 months
3.44 score on a scale
Standard Deviation 1.16
3.27 score on a scale
Standard Deviation 1.27
The Material Resources Survey
6 months
3.15 score on a scale
Standard Deviation 1.35
3.05 score on a scale
Standard Deviation 1.55
The Material Resources Survey
0 months
3.19 score on a scale
Standard Deviation 0.92
3.43 score on a scale
Standard Deviation 1.03
The Material Resources Survey
2 months
2.97 score on a scale
Standard Deviation 1.22
3.60 score on a scale
Standard Deviation 1.00

SECONDARY outcome

Timeframe: 0, 2, 4 months

Population: Participants analyzed were those who completed the required surveys at the specified timepoints and had valid data available for analysis.

Participants will complete the Everyday Discrimination Scale at baseline and after each session. Each response is assigned a value on the Likert scale ('never'=1 to 'almost every day'=6). Responses are averaged across items to produce a score ranging from 1 to 6. A higher score may indicate a higher perception of discrimination.

Outcome measures

Outcome measures
Measure
Wait-list Control -Delayed Intervention
n=30 Participants
A wait-list control design to safeguard ethical treatment of participants by ensuring that a potentially impactful intervention will be available to all after a brief waiting period. Delayed intervention (waitlist control): Wait-list control participants will be assigned to initiate the full intervention at month 2 after their enrollment (i.e., beginning after they and their corresponding intervention group have completed their intervention and one follow-up survey). Wait-list control participants will complete surveys at enrollment (baseline), 2 months (pre-intervention), 4 months (immediate post-intervention), and 6 months (endline).
Tele-B6
n=30 Participants
The tele-B6 intervention includes five group sessions delivered over the course of five weeks. Survey assessments for the intervention group will be conducted at enrollment (baseline), 2 months (immediate post-intervention survey), 4 months (interim-survey, post-intervention), and 6 months (endline). Tele-B6: Participants will be part of the Tele-B6 intervention that includes five group sessions delivered over the course of five weeks. Survey assessments for the intervention group (first phase) will be conducted at enrollment (baseline), 2 months (immediate post-intervention survey), 4 months (interim-survey, post-intervention), and 6 months (endline).
Everyday Discrimination Scale
0 months
1.73 score on a scale
Standard Deviation 1.74
1.59 score on a scale
Standard Deviation 1.78
Everyday Discrimination Scale
2 months
2.08 score on a scale
Standard Deviation 1.98
1.48 score on a scale
Standard Deviation 1.95
Everyday Discrimination Scale
4 months
2.22 score on a scale
Standard Deviation 2.30
1.85 score on a scale
Standard Deviation 2.11

SECONDARY outcome

Timeframe: 0, 2, 4, 6 months

Population: Participants analyzed were those who completed the required surveys at the specified timepoints and had valid data available for analysis.

Participants will complete the HIV stigma scale at baseline and after each session. This scale includes 10 items, stigma rated on a 5-point scale from "Strongly Disagree"= 1 to "Strongly Agree"=5. For scoring, items are averaged, with higher total scores indicating greater perceived HIV stigma.

Outcome measures

Outcome measures
Measure
Wait-list Control -Delayed Intervention
n=30 Participants
A wait-list control design to safeguard ethical treatment of participants by ensuring that a potentially impactful intervention will be available to all after a brief waiting period. Delayed intervention (waitlist control): Wait-list control participants will be assigned to initiate the full intervention at month 2 after their enrollment (i.e., beginning after they and their corresponding intervention group have completed their intervention and one follow-up survey). Wait-list control participants will complete surveys at enrollment (baseline), 2 months (pre-intervention), 4 months (immediate post-intervention), and 6 months (endline).
Tele-B6
n=30 Participants
The tele-B6 intervention includes five group sessions delivered over the course of five weeks. Survey assessments for the intervention group will be conducted at enrollment (baseline), 2 months (immediate post-intervention survey), 4 months (interim-survey, post-intervention), and 6 months (endline). Tele-B6: Participants will be part of the Tele-B6 intervention that includes five group sessions delivered over the course of five weeks. Survey assessments for the intervention group (first phase) will be conducted at enrollment (baseline), 2 months (immediate post-intervention survey), 4 months (interim-survey, post-intervention), and 6 months (endline).
Perception of HIV Stigma Scale
0 months
2.61 score on a scale
Standard Deviation 0.80
2.18 score on a scale
Standard Deviation 0.65
Perception of HIV Stigma Scale
2 months
2.53 score on a scale
Standard Deviation 0.77
2.11 score on a scale
Standard Deviation 0.78
Perception of HIV Stigma Scale
4 months
2.51 score on a scale
Standard Deviation 0.71
2.10 score on a scale
Standard Deviation 0.78
Perception of HIV Stigma Scale
6 months
2.38 score on a scale
Standard Deviation 0.87
2.16 score on a scale
Standard Deviation 0.89

SECONDARY outcome

Timeframe: 0, 2, 4, 6 months

Population: Participants analyzed were those who completed the required surveys at the specified timepoints and had valid data available for analysis.

Participants will complete the personal social capital scale. The Personal Social Capital Scale (PSCS) measures an individual's personal social capital, assessing both bonding capital (strong ties like family/close friends) and bridging capital (weaker ties to diverse groups) through cognitive (trust, reciprocity) and structural (network size, frequency) elements, to understand resources for health, support, and behavior. A five-point Likert scale is used to assess these questions, with 1 = none and 5 = all. A composite score will be derived by summarizing the item scores. The overall score range is typically 8 to 40 points. Higher scores indicate greater personal social capital, meaning the individual has a larger, more trustworthy social network with more resources and support available. Lower scores suggest fewer social connections and resources, which may be associated with increased stress or poorer health outcomes.

Outcome measures

Outcome measures
Measure
Wait-list Control -Delayed Intervention
n=30 Participants
A wait-list control design to safeguard ethical treatment of participants by ensuring that a potentially impactful intervention will be available to all after a brief waiting period. Delayed intervention (waitlist control): Wait-list control participants will be assigned to initiate the full intervention at month 2 after their enrollment (i.e., beginning after they and their corresponding intervention group have completed their intervention and one follow-up survey). Wait-list control participants will complete surveys at enrollment (baseline), 2 months (pre-intervention), 4 months (immediate post-intervention), and 6 months (endline).
Tele-B6
n=30 Participants
The tele-B6 intervention includes five group sessions delivered over the course of five weeks. Survey assessments for the intervention group will be conducted at enrollment (baseline), 2 months (immediate post-intervention survey), 4 months (interim-survey, post-intervention), and 6 months (endline). Tele-B6: Participants will be part of the Tele-B6 intervention that includes five group sessions delivered over the course of five weeks. Survey assessments for the intervention group (first phase) will be conducted at enrollment (baseline), 2 months (immediate post-intervention survey), 4 months (interim-survey, post-intervention), and 6 months (endline).
Personal Social Capital Scale
0 months
23.27 score on a scale
Standard Deviation 8.13
24.35 score on a scale
Standard Deviation 8.86
Personal Social Capital Scale
4 months
22.37 score on a scale
Standard Deviation 7.42
24.85 score on a scale
Standard Deviation 7.89
Personal Social Capital Scale
6 months
24.05 score on a scale
Standard Deviation 7.34
26.07 score on a scale
Standard Deviation 8.58
Personal Social Capital Scale
8 months
22.37 score on a scale
Standard Deviation 5.75
21.62 score on a scale
Standard Deviation 6.23

SECONDARY outcome

Timeframe: 0, 2, 4, 6 months

Population: Participants analyzed were those who completed the required surveys at the specified timepoints and had valid data available for analysis

Participants will complete the Studies Depression Scale (CES-D) survey. In scoring the CES-D, a value of 0, 1, 2, or 3 is assigned to a response depending upon whether the item is worded positively or negatively. The possible range of scores is 0 to 60, with the higher scores indicating greater symptomatology. The standard cut-off score on the 20-item Center for Epidemiologic Studies Depression Scale (CES-D) to indicate a risk for clinical depression is 16 or higher. Scores are interpreted as follows: 0-14: Mild or no depressive symptoms 15-23: Moderate or significant depressive symptoms 24 or higher: Severe depressive symptoms

Outcome measures

Outcome measures
Measure
Wait-list Control -Delayed Intervention
n=30 Participants
A wait-list control design to safeguard ethical treatment of participants by ensuring that a potentially impactful intervention will be available to all after a brief waiting period. Delayed intervention (waitlist control): Wait-list control participants will be assigned to initiate the full intervention at month 2 after their enrollment (i.e., beginning after they and their corresponding intervention group have completed their intervention and one follow-up survey). Wait-list control participants will complete surveys at enrollment (baseline), 2 months (pre-intervention), 4 months (immediate post-intervention), and 6 months (endline).
Tele-B6
n=30 Participants
The tele-B6 intervention includes five group sessions delivered over the course of five weeks. Survey assessments for the intervention group will be conducted at enrollment (baseline), 2 months (immediate post-intervention survey), 4 months (interim-survey, post-intervention), and 6 months (endline). Tele-B6: Participants will be part of the Tele-B6 intervention that includes five group sessions delivered over the course of five weeks. Survey assessments for the intervention group (first phase) will be conducted at enrollment (baseline), 2 months (immediate post-intervention survey), 4 months (interim-survey, post-intervention), and 6 months (endline).
Number of Participants With Studies Depression Scale Greater Than 16
0 months
16 Participants
16 Participants
Number of Participants With Studies Depression Scale Greater Than 16
2 months
14 Participants
12 Participants
Number of Participants With Studies Depression Scale Greater Than 16
4 months
12 Participants
12 Participants
Number of Participants With Studies Depression Scale Greater Than 16
6 months
11 Participants
12 Participants

SECONDARY outcome

Timeframe: 0, 2, 4, 6 months

Population: Participants analyzed were those who completed the required surveys at the specified timepoints and had valid data available for analysis.

Participants will complete the general well-being (GWB) survey. The General Well-Being Schedule (GWB) is designed to assess an individual's mental health or quality of life. The GWB consists of 18 items indicating subjective feelings of psychological well-being and distress. All of the items utilize the past month as the time frame of interest. The first 14 questions use a six-point rating scale that represents either intensity or frequency. The remaining items use a 0-10 rating scale that is anchored by adjectives. Because some items are reverse scored (items 1, 3, 6, 7, 9, 11, 15, and 16), 14 is subtracted from the total score, yielding a total possible range of scores from 0 to 110. Low scores represent greater distress. Proposed cutoffs representing three levels of distress are 0-60 (severe distress), 61-72 (moderate distress), and 73-110 (positive well-being).

Outcome measures

Outcome measures
Measure
Wait-list Control -Delayed Intervention
n=30 Participants
A wait-list control design to safeguard ethical treatment of participants by ensuring that a potentially impactful intervention will be available to all after a brief waiting period. Delayed intervention (waitlist control): Wait-list control participants will be assigned to initiate the full intervention at month 2 after their enrollment (i.e., beginning after they and their corresponding intervention group have completed their intervention and one follow-up survey). Wait-list control participants will complete surveys at enrollment (baseline), 2 months (pre-intervention), 4 months (immediate post-intervention), and 6 months (endline).
Tele-B6
n=30 Participants
The tele-B6 intervention includes five group sessions delivered over the course of five weeks. Survey assessments for the intervention group will be conducted at enrollment (baseline), 2 months (immediate post-intervention survey), 4 months (interim-survey, post-intervention), and 6 months (endline). Tele-B6: Participants will be part of the Tele-B6 intervention that includes five group sessions delivered over the course of five weeks. Survey assessments for the intervention group (first phase) will be conducted at enrollment (baseline), 2 months (immediate post-intervention survey), 4 months (interim-survey, post-intervention), and 6 months (endline).
General Well-being (GWB) Survey
0 months
60.3 score on a scale
Standard Deviation 20.0
66.2 score on a scale
Standard Deviation 14.4
General Well-being (GWB) Survey
2 months
60.6 score on a scale
Standard Deviation 19.3
71.8 score on a scale
Standard Deviation 17.2
General Well-being (GWB) Survey
4 months
63.67 score on a scale
Standard Deviation 17.6
65.7 score on a scale
Standard Deviation 16.4
General Well-being (GWB) Survey
6 months
65.9 score on a scale
Standard Deviation 20.5
68.8 score on a scale
Standard Deviation 19.0

OTHER_PRE_SPECIFIED outcome

Timeframe: Exit of study (up to 6 months)

Participants will be asked to complete surveys with open-ended questions adapted from the original B6 exit interview guide. There is no summary score of the open-ended questions asked during the interview.

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: Exit of study (up to 6 months)

Participants will be asked to complete open-ended questions adapted from the original B6 exit interview guide. There is no summary score of the open-ended questions asked during the interview.

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 0, 2, 4, 6 months

Participants will complete the multidimensional model of black identity lesbian, gay, and bisexual identity scale,

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: Exit of study (up to 6 months)

Participants will be asked to complete open-ended questions adapted from the original B6 exit interview guide. There is no summary score of the open-ended questions asked during the interview.

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: Exit of study (up to 6 months)

Participants will be asked to complete open-ended questions adapted from the original B6 exit interview guide. There is no summary score of the open-ended questions asked during the interview.

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: Exit of study (up to 6 months)

Participants will be asked to complete surveys with open-ended questions adapted from the original B6 exit interview guide. There is no summary score of the open-ended questions asked during the interview.

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: Exit of study (up to 6 months)

Participants will be asked to complete open-ended questions adapted from the original B6 exit interview guide. There is no summary score of the open-ended questions asked during the interview.

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 0, 2, 4, 6 months

Participants will be asked to complete surveys and matched to a Zipcode to derive neighborhood measures.

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 0, 2, 4, 6 months

Participants will complete the Internalized Homonegativity Inventory at baseline and after each session. This 26-item scale has four subscales: (a) Public Identification as Gay, (b) Perception of Stigma Associated with Being Gay, (c) Social Comfort with Gay Men, (d) Moral and Religious Acceptability of Being Gay.

Outcome measures

Outcome data not reported

OTHER_PRE_SPECIFIED outcome

Timeframe: 0 and 6 months

The research team will review the electronic medical record (EMR) to abstract HIV viral load information

Outcome measures

Outcome data not reported

Adverse Events

Wait-list Control -Delayed Intervention

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Tele-B6

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Sophia A. Hussen, MD, MPH

Emory University

Phone: 404-616-2440

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place